Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLN-177 in Recurrent Calcium Oxalate Kidney Stone Formers
NCT02503345Phase 2Completed
- Sponsor
- Allena Pharmaceuticals, Inc.
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of reloxaliase in secondary hyperoxaluria, nephrolithiasis, sponsored by Allena Pharmaceuticals, Inc.. Started Jul 2015; status: completed.
02
Drugs
reloxaliase
03
Conditions
secondary hyperoxalurianephrolithiasis
Beyond the preview
Go deeper on NCT02503345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503345.